Vorinostat Completed Phase 1 Trials for Multiple Myeloma (MM) / Lung Cancer Non-Small Cell Cancer (NSCLC) / Malignant Neoplasm of Pancreas / Melanoma / Malignant Lymphomas Other

IndicationsStatusPurposePhase
CompletedOther1
clinicaltrials.gov IdentifierTitleDrugs
NCT00731952Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer
NCT00667082NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma